about
MicroRNAs: promising new antiangiogenic targets in cancerCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis.Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung CancerSerum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia.Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Update on biomarkers for the detection of lung cancer.miRNA detection methods and clinical implications in lung cancer.Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups.Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells.Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.Oncological translational research in the Spanish national health system: the INTRO study.The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients.New insights in non-small-cell lung cancer: circulating tumor cells and cell-free DNA.Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project.BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia.Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer.Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression.Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.The prognostic value of hTERT expression levels in advanced-stage colorectal cancer patients: a comparison between tissue and serum expression.Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients.EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde taleMolecular subtypes in early colorectal cancer associated with clinical features and patient prognosisCombined VEGF-A and VEGFR-2 concentrations in plasma: Diagnostic and prognostic implications in patients with advanced NSCLCFifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology WorkshopZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemiaBortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutationsA profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancerLung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancerClinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotypingIdentification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC PatientsClinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistanceOsimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma
P50
Q27027998-4E008531-7AE2-4409-AA10-8C0C154DA47DQ28077340-691BA40C-7B57-4F2D-B8AD-6D0FDD63DBD9Q33599123-CF721E44-9C9F-4D17-9E7B-F45ABF2E9CDBQ35826391-E46A8BB8-5237-4D9F-8893-15D5ABD761EAQ37022332-0667EBE0-79D6-46BD-88CD-67931436D98EQ37082690-088CE001-2927-4A7C-A109-0D51FBDA4AABQ37180356-E8C04354-8782-4B7B-93BE-B30226A37BECQ37619675-D5E9387D-990B-404B-BBB7-03D8E761F616Q37645219-47BF7753-CA8C-4B91-8614-B19621596C9BQ38282466-43457B78-B87E-4F9A-9013-1F30A9EBBF31Q38511275-E16A9ED4-A284-4B64-B000-E8E405C26091Q38814642-7D4AD36F-B39F-4419-A7C4-0FDBF9E753E1Q38961444-C73BD434-5E70-4120-A811-E9434F3AFB41Q39301152-51CA3FF2-42E2-41D9-9B9E-5C3CC599782CQ44197652-D66CD007-F934-4C09-91C9-5B25D564EAC3Q47159366-EA46F400-3448-4CB4-B4A0-0D67EFB2D539Q47397397-C8F7AAD3-1A54-4504-AE12-AE5591D4A11AQ48006719-493685B2-5ECF-4BF6-8F36-FFC4737337A9Q49447563-66D93598-3BAE-4A85-AE00-84E2BC513A99Q49645578-EABF1BCE-D1D2-4EA2-8F24-957F85FE73D4Q50025565-AD7B9C00-DF1F-4370-93F3-E80C0C5DA511Q53385070-DFA3B611-9D1C-435B-8C10-43878F768964Q54238539-C5D0C07D-327D-4CC2-BB16-B353775C16BAQ54364360-8118B50B-30C0-4591-B747-14C403B0C3E6Q54391726-E81CC77F-4CF2-488F-ACAF-CF468076AAC0Q54576549-B60E6DC2-1A6F-437F-A5E1-4A28612F5A0DQ63441291-B20E9B28-9970-4E37-9463-458731BB52D7Q63441293-191189DF-450E-40D2-B99F-2DE02319FF57Q63441350-1C04EB39-9CDD-4B24-9555-F0BDE7B5707EQ63441351-B3EE4E04-D3A1-4AE4-B09C-70D1221A257AQ63441386-E75C16BD-48C4-40D8-8C65-432B100417CAQ63441392-F05A86E0-E2E9-4EE2-9BDF-DCF0AD578123Q89500625-B285848F-081E-49C7-BDF5-F8A76F91EC69Q90044676-89E67BB6-F28C-4853-A375-43D410D30AB8Q90392076-4DEE78A7-E545-4266-9496-D58C85DC97D6Q90975009-09C1D986-5BF3-4106-8100-FCBF5EB20DC7Q91399344-70AF58E5-FA2B-4DDE-87A3-1B5059837EECQ91808643-4B35925F-CC25-47DF-B4B1-DCC53FA33E47Q91998054-8C2E329D-A808-41CA-BD39-B90021FB3DDAQ92593655-3D0A202B-8D75-4704-830C-279DE2B3B267
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eloisa Jantus Lewintre
@ast
Eloisa Jantus Lewintre
@en
Eloisa Jantus Lewintre
@es
Eloisa Jantus Lewintre
@nl
Eloisa Jantus Lewintre
@sl
type
label
Eloisa Jantus Lewintre
@ast
Eloisa Jantus Lewintre
@en
Eloisa Jantus Lewintre
@es
Eloisa Jantus Lewintre
@nl
Eloisa Jantus Lewintre
@sl
altLabel
E Jantus
@en
EJ Lewintre
@en
Eloisa Jantus Lewintre
@en
Eloisa Jantus
@en
Eloisa Jantus-Lewintre
@en
Eloisa Jantús
@en
Eloísa Jantus Lewintre
@en
Eloísa Jantus-Lewintre
@en
Eloísa Jantús
@en
prefLabel
Eloisa Jantus Lewintre
@ast
Eloisa Jantus Lewintre
@en
Eloisa Jantus Lewintre
@es
Eloisa Jantus Lewintre
@nl
Eloisa Jantus Lewintre
@sl
P1053
B-4630-2009
P106
P1153
24597450300
P21
P31
P3829
P3835
eloisa-jantus-lewintre
P496
0000-0001-7395-4380